COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes from Delta AY.4.2: Cohort and test-negative study of 5.4 million individuals in ScotlandDelta AY.4.2의 증상이 있는 SARS-CoV-2 감염 및 심각한 COVID-19 결과에 대한 COVID-19 백신 효과: 스코틀랜드의 540만 개인에 대한 코호트 및 테스트 음성 연구Article Published on 2022-07-092022-09-11 Journal: Journal of Global Health [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] 95% CI 95% confidence interval accounted acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Adults age BNT162b2 ChAdOx1 Chain Reaction cohort study Community conditions conducted confounders contributed coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 admission COVID-19 hospitalisation COVID-19 vaccine Cox proportional hazard Cox proportional hazards model death Delta Effectiveness enhanced Good hazard ratio Hospital admission increased risk individual individuals Infection Lineage mRNA mRNA-1273 mRNA-1273 vaccine mRNA-1273 vaccines offered omicron Omicron variant outcome performed platform polymerase chain polymerase chain reaction proportional hazards model provided reverse transcriptase Reverse transcriptase polymerase chain reaction RT-PCR SARS-CoV-2 SARS-COV-2 infection second vaccination security severe acute respiratory syndrome Coronavirus severe COVID-19 Sex socioeconomic status spline splines symptomatic symptomatic COVID-19 symptomatic infection symptomatic SARS-CoV-2 infection transcriptase United Kingdom vaccination Vaccine vaccine dose Vaccines variant variant of SARS-CoV-2 were infected [DOI] 10.7189/jogh.12.05025 PMC 바로가기 [Article Type] Article
Intravenous IgM-enriched immunoglobulins in critical COVID-19: a multicentre propensity-weighted cohort study중요한 COVID-19에서 정맥내 IgM이 풍부한 면역글로불린: 다기관 성향 가중 코호트 연구Multicenter Study Published on 2022-07-072022-09-12 Journal: Critical Care [Category] COVID19(2023년), SARS, 진단, [키워드] 30-Day mortality acute respiratory distress addition applied Characteristics clinical clinically Cohort cohort study Complication concerning confidence interval controls coronavirus disease COVID-19 COVID-19 patients Cox regression models Critical Critically ill Critically ill patient daily dose dose early administration Effect Efficacy high mortality ICU ICU Patients Immunoglobulin immunoglobulin M immunoglobulins Inflammatory intravenous laboratory-confirmed Lung injury mechanical ventilation mechanically ventilated Mortality multicentre overcome Patient Primary outcome randomization randomized clinical trials retrospective SARS-CoV-2 selection bia statistical significance statistically statistically significant difference subgroup analysis subgroups survival treated Treatment treatment regimen two group was performed Weighting with COVID-19 [DOI] 10.1186/s13054-022-04059-0 PMC 바로가기 [Article Type] Multicenter Study
Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY영국에서 두 번째 백신 접종 후 COVID-19 백신 돌파구를 경험한 인구 설명: OpenSAFELY의 코호트 연구Article Published on 2022-07-052022-09-11 Journal: BMC Medicine [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI Admission analyses approval can not Care Characteristics Chronic kidney disease circulating cohort study concerning conducted COVID-19 COVID-19 vaccine Critical care database death described Describing determine dialysis effective EHR EHR data England follow-up time group groups haematological malignancy helping higher risk highest Hospital admissions Immunocompromised incidence rate increase individual Kidney disease majority malignancy median Mild NHS omicron Omicron variant OpenSAFELY Patient positive registry data reported retrospective cohort study risk routine clinical data SARS-CoV-2 test SARS-CoV-2 variant SARS-CoV-2 variants second vaccination secondary care the vaccine Transplant vaccinated against COVID-19 vaccinated individuals Vaccine Vaccine breakthrough variant variants while [DOI] 10.1186/s12916-022-02422-0 PMC 바로가기 [Article Type] Article
Post-COVID-19 Conditions Among Children 90 Days After SARS-CoV-2 InfectionSARS-CoV-2 감염 90일 후 어린이의 코로나19 이후 상태Article Published on 2022-07-012022-09-11 Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 치료기술, [키워드] 48 hour 48 hours 95% CI acute illness addition adjusted odds ratio age children cohort study condition conditions conducted controls country Day defined enrolled Factor fatigue Follow-up Frequency Health Hospitalization Hospitalized index IQR median age nucleic acid nucleic acid testing Older outcome positive positive test result problem proportion prospective cohort study recruitment reported risk risk factor Risk factors SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 positivity Symptom test result tested the median weakness [DOI] 10.1001/jamanetworkopen.2022.23253 PMC 바로가기 [Article Type] Article
A historical cohort study to investigation of statins safety in COVID-19 hospitalized patientsResearch article Published on 2022-07-012022-10-05 Journal: Thérapie [Category] COVID19(2023년), SARS, 신약개발, [키워드] 95% CI addition Admission age anti-inflammatory properties association cardiovascular diseases Chronic kidney disease CKD cohort study condition conditions Corticosteroids COVID COVID-19 COVID-19 infected patients COVID-19 patient COVID19 decrease diabetes evaluated groups hospital Hospitalization hospitalized COVID-19 patients hospitalized patient hypertension ICU ICU admission implementation Inflammatory marker inhibitor intensive care Mortality mortality rate notable Odds ratio outcome proportion Result SARS-CoV-2 severity Sex shown significant difference significantly single-center statin statins statistical analysis Statistics stroke Tehran variable was performed [DOI] 10.1016/j.therap.2021.10.006 [Article Type] Research article
Six-Month Quality of Life in COVID-19 Intensive Care Unit SurvivorsResearch article Published on 2022-07-012022-10-05 Journal: Journal of cardiothoracic and vascular anesthesia [Category] 신약개발, [키워드] 95% confidence interval age body mass index cohort study Coronavirus 2019 COVID-19 Critical care decrease Deterioration discharge Evidence female Health hospital ICU increase in intensive care intensive care unit life low molecular weight heparin measurement medical history Mental mental health Mortality Multivariate analysis objective Odds ratio participant Patient patients patients died physical poor quality predictor Prospective Quality quality life Quality of life questionnaire responders Result SARS-CoV-2 setting Sex significantly survivor Survivors Treatment was used [DOI] 10.1053/j.jvca.2021.08.036 [Article Type] Research article
Reduced fixed dose tocilizumab 400 mg IV compared to weight-based dosing in critically ill patients with COVID-19: A before-after cohort studyResearch article Published on 2022-07-012022-10-05 Journal: The Lancet Regional Health - Americas [Category] 바이오마커, [키워드] 28-day mortality assumed benefit Clinical outcome Cohort cohort study comparable cost-effectiveness Covid cytokine storm COVID-19 COVID-19 patient Critically ill Critically ill patient CRP demonstrated Dexamethasone dose equity family feasible finding fixed dose foundation funding groups Inflammation inhibitor interleukin-6 no significant difference pair-wise comparison Patient patients physiological response receiving reduce mortality reduction response Scholarship severe COVID-19 supported Taylor the patient threshold Tocilizumab treated with COVID-19 [DOI] 10.1016/j.lana.2022.100228 [Article Type] Research article
COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records영국 성인 5,700만 명 사이의 COVID-19 궤적: 전자 건강 기록을 사용한 코호트 연구Article Published on 2022-07-012022-09-11 Journal: International Journal of Environmental Research an [Category] COVID19(2023년), MERS, SARS, 신약개발, 진단, 치료기술, [키워드] Analysis can be used clinical pathways clinically Cohort cohort study collected COVID-19 COVID-19 phenotype COVID-19 testing COVID-19-related death Data science dataset death death certificate defined diagnose Diagnosis died disease severity disease trajectories disease trajectory EHR eight Electronic health record Electronic health records England estimate event Evidence evidence of FIVE foundation Frequency generate Health Data Research UK heart highest hospital Hospital admission ICU identify incidence individual individuals infection rate intensive care intensive care unit invasive ventilation MONITOR Mortality mortality data National Health Service NHS non-invasive ventilation occurred pandemic Pathways Patient patients Phenotypes positive primary care progression provided recorded remained SARS-CoV-2 test Science secondary care shown Stage stratified study period survival to define Trajectories trajectory vaccination Vaccination Status Ventilation ventilatory support Wave [DOI] 10.1016/S2589-7500(22)00091-7 PMC 바로가기 [Article Type] Article
Incidence and clinical phenotype of multisystem inflammatory syndrome in children after infection with the SARS-CoV-2 delta variant by vaccination status: a Danish nationwide prospective cohort study예방 접종 상태에 따른 SARS-CoV-2 델타 변이체 감염 후 소아에서 다기관 염증 증후군의 발병률 및 임상 표현형: 덴마크 전국 전향 코호트 연구Article Published on 2022-07-012022-09-11 Journal: The Lancet. Child & adolescent health [Category] COVID19(2023년), SARS, 변종, 임상, [키워드] 95% CI B.1.617.2 Breakthrough infection calculated center children clinical phenotype Cohort cohort study comparable contribute Control COVID-19 Data collection delta variant Delta wave Denmark disease disease control education Effectiveness Factors higher education hospitalised incidence individual infected individuals Infection infection with SARS-CoV-2 Inflammatory Innovation MIS-C number of infected occur pandemic Patient phenotype Poisson regression population-based cohort prevention prospective cohort study rate ratio Registered Research SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 variant Science Surveillance syndrome the SARS-CoV-2 vaccinated individual vaccination Vaccination Status Vaccine variant variant of SARS-CoV-2 was obtained [DOI] 10.1016/S2352-4642(22)00100-6 PMC 바로가기 [Article Type] Article
Long-term Immune Response to SARS-CoV-2 Infection Among Children and Adults After Mild Infection경증 감염 후 소아 및 성인의 SARS-CoV-2 감염에 대한 장기 면역 반응Article Published on 2022-07-012022-09-12 Journal: JAMA Network Open [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] age Analysis anti-SARS-CoV-2 antibody Asymptomatic chemiluminescent immunoassay children clinic Cluster Cohort cohort study COVID-19 COVID-19 vaccination demonstrated Department enrolled Evidence family Follow-up follow-up time help IgG IgG titer immune response individual Infection Italian longitudinal median Mild Older older patient parent Patient pediatric persistence prospective cohort study provide quantification response S-RBD SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection significantly higher single-center spike receptor-binding domain study participant Study participants sustained understanding university Vaccination strategies [DOI] 10.1001/jamanetworkopen.2022.21616 PMC 바로가기 [Article Type] Article